Risultati della ricerca - Karl Staser
- Mostra 1 - 15 risultati su 15
-
1
Mast cells and the neurofibroma microenvironment di Karl Staser, Feng‐Chun Yang, D. Wade Clapp
Pubblicazione 2010Revisão -
2
Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression di Karl Staser, Feng‐Chun Yang, D. Wade Clapp
Pubblicazione 2011Revisão -
3
The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia di Mark A. Schroeder, Jaebok Choi, Karl Staser, John F. DiPersio
Pubblicazione 2017Revisão -
4
-
5
-
6
-
7
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease di Jaebok Choi, Matthew Cooper, Karl Staser, Kidist Ashami, Kiran Vij, Bing Wang, Lynne Marsala, Jessica Niswonger, Julie Ritchey, Bader Alahmari, Samuel Achilefu, Ikuo Tsunoda, Mark A. Schroeder, John F. DiPersio
Pubblicazione 2018Artigo -
8
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity di Miriam Kim, Reyka G. Jayasinghe, Jessica M. Devenport, Julie Ritchey, Michael P. Rettig, Julie O’Neal, Karl Staser, Krista Kennerly, Alun Carter, Feng Gao, Byung Ha Lee, Matthew Cooper, John F. DiPersio
Pubblicazione 2022Artigo -
9
An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies di Jingyu Xiang, Jessica M. Devenport, Alun Carter, Karl Staser, Miriam Kim, Julie O’ Neal, Julie Ritchey, Michael P. Rettig, Feng Gao, Garrett R. Rettig, Rolf Turk, Byung Ha Lee, Matthew Cooper, John F. DiPersio
Pubblicazione 2023Artigo -
10
Hyperactive Transforming Growth Factor-β1 Signaling Potentiates Skeletal Defects in a Neurofibromatosis Type 1 Mouse Model di Steven D. Rhodes, Xiaohua Wu, Yongzheng He, Shi Chen, Hao Yang, Karl Staser, Jiapeng Wang, Ping Zhang, Chang Jiang, Hiroki Yokota, Ruizhi Dong, Xianghong Peng, Xianlin Yang, Sreemala Murthy, Mohamad Azhar, Khalid S. Mohammad, Mingjiang Xu, Theresa A. Guise, Feng‐Chun Yang
Pubblicazione 2013Artigo -
11
A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease di Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael A. Pratta, Miguel‐Angel Perales, Yi‐Bin Chen, Gabrielle Meyers, John F. DiPersio
Pubblicazione 2020Artigo -
12
An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies di Matthew Cooper, Jaebok Choi, Karl Staser, Julie Ritchey, Jessica M. Devenport, Kayla Eckardt, Michael P. Rettig, Bing Wang, Linda Eissenberg, Armin Ghobadi, Leah Gehrs, Julie L. Prior, Samuel Achilefu, Christopher A. Miller, Catrina C. Fronick, Julie O’Neal, Feng Gao, David M. Weinstock, Alejandro Gutiérrez, Robert S. Fulton, John F. DiPersio
Pubblicazione 2018Artigo -
13
A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation di Jeffrey R. Gehlhausen, Su-Jung Park, Ann E. Hickox, Matthew Shew, Karl Staser, Steven D. Rhodes, K.M.J. Menon, Jacquelyn D. Lajiness, Muithi Mwanthi, Xianlin Yang, Jin Yuan, Paul R. Territo, Gary D. Hutchins, Grzegorz Nalepa, Feng‐Chun Yang, Simon J. Conway, Michael G. Heinz, Anat Stemmer‐Rachamimov, Charles W. Yates, D. Wade Clapp
Pubblicazione 2014Artigo -
14
Identification of molecular compartments and genetic circuitry in the developing mammalian kidney di Jing Yu, M. Todd Valerius, Mary Duah, Karl Staser, Jennifer K. Hansard, Jinjin Guo, Jill A. McMahon, Joe E Vaughan, Diane Faria, Kylie Georgas, Bree Rumballe, Qun Ren, A. Michaela Krautzberger, Jan Philipp Junker, Rathi D. Thiagarajan, Philip Machanick, Paul A. Gray, Alexander van Oudenaarden, David H. Rowitch, Charles D. Stiles, Qiufu Ma, Sean M. Grimmond, Timothy L. Bailey, Melissa H. Little, Andrew P. McMahon
Pubblicazione 2012Artigo -
15
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial di Kent A. Robertson, Grzegorz Nalepa, Feng‐Chun Yang, Daniel C. Bowers, Chang Yueh Ho, Gary D. Hutchins, James M. Croop, Terry A. Vik, Scott C. Denne, Luis F. Parada, Cynthia M. Hingtgen, Laurence E. Walsh, Menggang Yu, Kamnesh R. Pradhan, Mary Edwards‐Brown, Mervyn D. Cohen, James Fletcher, Jeffrey B. Travers, Karl Staser, Melissa W. Lee, Marcie R. Sherman, Cynthia J. Davis, Lucy Miller, David A. Ingram, D. Wade Clapp
Pubblicazione 2012Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Biology
Immunology
Cancer research
Genetics
Cell biology
Internal medicine
Pathology
Immune system
Neurofibromatosis
Gene
Stem cell
Cytokine
Disease
Graft-versus-host disease
Haematopoiesis
In vitro
Neurofibroma
Neurofibromin 1
Plexiform neurofibroma
T cell
Adverse effect
Antigen
Chimeric antigen receptor
Endocrinology
Gastroenterology
Interleukin
Interleukin 2
Leukemia
Lymphoma